Several studies suggested a potential prognostic value of VEGF in NSCLC but so far investigations into circulating VEGF levels have not yielded consistent results (Rodríguez Garzotto et al., 2016). This evidence concerns the gene VEGFA and non-small cell lung carcinoma.